Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90754819
Filing Date:06/04/2021
To the Commissioner for Trademarks:
MARK: TEDENZI (Standard Characters, see mark)
The literal element of the mark consists of TEDENZI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Coherus BioSciences, Inc., a corporation of Delaware, having an address of
333 Twin Dolphin Dr, Suite 600
Redwood City, California 94065
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for the prevention and treatment of auto-immune, inflammatory, hematological, hepatological, cardiovascular, pulmonary, central nervous
system, neurological system, pain, inflammation, dermatologic, gastro-intestinal, hormonal, psychiatric, infectious-related, viral, metabolic, oncologic, ophthalmic, respiratory, digital ulcers,
musculo-skeletal, genitourinary, sexual dysfunction, and cerebrovascular diseases and disorders; vaccines; anxiolytics; anti-allergics; anti-infectives
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Anthony Malutta. Other appointed attorneys are all other trademark attorneys. Anthony Malutta of Kilpatrick Townsend & Stockton LLP, is a
member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
Two Embarcadero Center, Suite 1900
San Francisco, California 94111
United States
415-576-0200(phone)
415-576-0300(fax)
tmadmin@kilpatricktownsend.com
The docket/reference number is 1254650.
Anthony Malutta submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Andy Chan/ Date: 06/04/2021
Signatory's Name: Andy Chan
Signatory's Position: Vice President Intellectual Property & Litigation
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90754819
Payment Accounting Date: 06/04/2021
Serial Number: 90754819
Internet Transmission Date: Fri Jun 04 13:18:34 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2021060413183495
3999-90754819-7801e79ab6a582ea7b73a6c240
e26750acce4858da3ab365eb41762f2830124e6-
CC-18331957-20210601191621033135